Micro-plasma radiofrequency and silicone gel dressings for treating early post-traumatic facial scars: A retrospective study.


Journal

Journal of plastic, reconstructive & aesthetic surgery : JPRAS
ISSN: 1878-0539
Titre abrégé: J Plast Reconstr Aesthet Surg
Pays: Netherlands
ID NLM: 101264239

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 30 03 2023
revised: 29 08 2023
accepted: 07 09 2023
medline: 5 12 2023
pubmed: 8 10 2023
entrez: 7 10 2023
Statut: ppublish

Résumé

Although different options are available for treating post-traumatic facial scars, they remain a therapeutic challenge. To evaluate the safety and effectiveness of combined therapy using micro-plasma radiofrequency (MPRF) technology and silicone gel (SG) dressings for treating post-traumatic facial scars. This retrospective study was conducted at a single center. Patients with facial injuries in the outpatient and emergency units of the Department of Plastic Surgery at our hospital underwent debridement and cosmetic sutures performed by the same surgeon from October 2020 to October 2021. In the first arm, patients with facial injuries were treated with MPRF technology and SG, and in the second arm, they were treated with SG dressings alone. We observed the safety and effectiveness of these treatments in both arms. A total of 32 patients with facial injuries were treated with MPRF technology and SG dressings (combined treatment group), and 28 patients were treated with SG dressings alone (SG group). After 6 months of treatment, the Vancouver Scar Scale scores of the combined treatment and SG groups were 1.38 ± 0.71 and 4.39 ± 0.50, respectively, and the difference was statistically significant (P < 0.01). After 6 months of treatment, the effectiveness rate in the combined treatment group was 93.8%, which was significantly higher than that in the SG group (67.9%), and the difference between the two groups was statistically significant (P < 0.05). No obvious adverse reactions occurred in the two arms. Treating early post-traumatic facial scars with combined MPRF technology and SG is significantly better than treating them with SG alone; moreover, the combined therapy is safe and effective.

Sections du résumé

BACKGROUND BACKGROUND
Although different options are available for treating post-traumatic facial scars, they remain a therapeutic challenge.
AIM OBJECTIVE
To evaluate the safety and effectiveness of combined therapy using micro-plasma radiofrequency (MPRF) technology and silicone gel (SG) dressings for treating post-traumatic facial scars.
METHODS METHODS
This retrospective study was conducted at a single center. Patients with facial injuries in the outpatient and emergency units of the Department of Plastic Surgery at our hospital underwent debridement and cosmetic sutures performed by the same surgeon from October 2020 to October 2021. In the first arm, patients with facial injuries were treated with MPRF technology and SG, and in the second arm, they were treated with SG dressings alone. We observed the safety and effectiveness of these treatments in both arms.
RESULTS RESULTS
A total of 32 patients with facial injuries were treated with MPRF technology and SG dressings (combined treatment group), and 28 patients were treated with SG dressings alone (SG group). After 6 months of treatment, the Vancouver Scar Scale scores of the combined treatment and SG groups were 1.38 ± 0.71 and 4.39 ± 0.50, respectively, and the difference was statistically significant (P < 0.01). After 6 months of treatment, the effectiveness rate in the combined treatment group was 93.8%, which was significantly higher than that in the SG group (67.9%), and the difference between the two groups was statistically significant (P < 0.05). No obvious adverse reactions occurred in the two arms.
CONCLUSION CONCLUSIONS
Treating early post-traumatic facial scars with combined MPRF technology and SG is significantly better than treating them with SG alone; moreover, the combined therapy is safe and effective.

Identifiants

pubmed: 37804642
pii: S1748-6815(23)00499-0
doi: 10.1016/j.bjps.2023.09.004
pii:
doi:

Substances chimiques

Silicone Gels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-16

Informations de copyright

Copyright © 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have stated explicitly that there are no conflicts of interest in connection with this article.

Auteurs

Jiao Kong (J)

China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun 130033, China.

Changcai Zhou (C)

China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun 130033, China.

Lingfeng Pan (L)

China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun 130033, China.

Mingxi Li (M)

China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun 130033, China.

Lianbo Zhang (L)

China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun 130033, China. Electronic address: lianbo@jlu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH